Flurazepam Hydrochloride Capsule Shortage: Current FDA Status and Availability Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has reported an ongoing shortage of Flurazepam Hydrochloride capsules, though current data indicates some presentations remain available from specific manufacturers.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Flurazepam-Hydrochloride.
What's in Shortage
Flurazepam Hydrochloride is currently listed in the FDA Drug Shortage Database. This medication, available under the brand name FLURAZEPAM HYDROCHLORIDE, is provided in capsule form. It is categorized under Oncology and Other therapeutic categories. The shortage was first posted on August 3, 2022, and the status was last updated on February 2, 2026.
Which Manufacturers Are Affected
Currently, the following manufacturer is listed with the associated availability status for Flurazepam Hydrochloride capsules:
- Chartwell Molecular Holdings LLC
- Status: Available
- Presentations:
- 15 mg Capsule (NDC 62135-736-90)
- 15 mg Capsule (NDC 62135-736-30)
- 30 mg Capsule (NDC 62135-737-90)
- 30 mg Capsule (NDC 62135-737-30)
- Contact Information: 845-268-5000 Ext. 510
Why There's a Shortage
The FDA source data does not provide a specific reason for the current shortage status of Flurazepam Hydrochloride capsules.
What Patients Should Do
If you are prescribed Flurazepam Hydrochloride and are having difficulty filling your prescription, please consider the following steps:
- Consult Your Healthcare Provider: Speak with your doctor regarding your treatment plan. Do not make any changes to your medication regimen without professional medical advice.
- Talk to Your Pharmacist: Your pharmacist may have information on local stock levels or may be able to assist in locating the medication from different suppliers.
- Contact the Manufacturer: You may reach out to Chartwell Molecular Holdings LLC at 845-268-5000 Ext. 510 for further information regarding their current supply.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medication availability and treatment alternatives.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.